DK1868454T3 - Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning - Google Patents

Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning

Info

Publication number: DK1868454T3
Authority: DK; Denmark
Prior art keywords: composition; glucose control; insulin effect; nutritional improvement; nutritional
Prior art date: 2005-04-06

Application number

DK06749290.0T

Other languages

English (en)

Inventor

Kenneth C Hayes

Norman Alan Greenberg

John P Troup

Anne L Falk

Gianni Biolo

Original Assignee

Nestec Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-06

Filing date

2006-04-04

Publication date

2013-04-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36661519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1868454(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-04-04 Application filed by Nestec Sa filed Critical Nestec Sa

2013-04-02 Application granted granted Critical

2013-04-02 Publication of DK1868454T3 publication Critical patent/DK1868454T3/da

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
239000008103 glucose Substances 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
235000016709 nutrition Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Natural Medicines & Medicinal Plants (AREA)
Mycology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Botany (AREA)
Hematology (AREA)
Obesity (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)

DK06749290.0T 2005-04-06 2006-04-04 Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning DK1868454T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66863305P	2005-04-06	2005-04-06
PCT/US2006/012576 WO2006108008A2 (en)	2005-04-06	2006-04-04	A method and composition for nutritionally improving glucose control and insulin action

Publications (1)

Publication Number	Publication Date
DK1868454T3 true DK1868454T3 (da)	2013-04-02

Family

ID=36661519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06749290.0T DK1868454T3 (da)	2005-04-06	2006-04-04	Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning

Country Status (16)

Country	Link
US (2)	US8067359B2 (da)
EP (3)	EP2243383A3 (da)
JP (3)	JP5788631B2 (da)
CN (2)	CN105394748A (da)
AU (2)	AU2006231557B2 (da)
BR (1)	BRPI0608610A2 (da)
CA (1)	CA2601427C (da)
DK (1)	DK1868454T3 (da)
ES (1)	ES2419205T3 (da)
IL (1)	IL186005A0 (da)
MX (1)	MX2007012450A (da)
PT (1)	PT1868454E (da)
RU (1)	RU2421076C2 (da)
SG (1)	SG161234A1 (da)
WO (1)	WO2006108008A2 (da)
ZA (1)	ZA200707825B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8283327B2 (en)	2005-03-19	2012-10-09	Kneller Bruce W	Palatinose for enhancing dietary supplement and pharmaceutical delivery
EP2243383A3 (en) *	2005-04-06	2011-02-16	Nestec S.A.	A method and composition for nutritionally improving glucose control and insulin action
AU2007267560B2 (en)	2006-05-26	2010-10-21	Nestec S.A.	Methods of use and nutritional compositions of Touchi Extract
WO2008054193A1 (en) *	2006-11-02	2008-05-08	N.V. Nutricia	Nutritional products that comprise saccharide oligomers
JP5931324B2 (ja) *	2008-01-09	2016-06-08	ニュートリー株式会社	がん化学療法時に起こる酸化ストレス及び／又は副作用の軽減あるいはがん化学療法時の栄養状態を改善するための組成物
US8071143B2 (en) *	2008-04-02	2011-12-06	Brandeis University	Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
ES2583602T3 (es) *	2008-05-07	2016-09-21	Vegenat, S.A.	Mezcla de hidratos de carbono y su utilización para preparar un producto destinado a la alimentación oral o enteral
WO2009135959A1 (es) *	2008-05-07	2009-11-12	Katry Inversiones, S.L.	Producto alimenticio para la nutrición por vía enteral u oral del paciente diabético
US9345731B2 (en)	2008-08-27	2016-05-24	Pt. Dexa Medica	Herbal extract as sensitivity enhancer toward insulin and antidiabetes
US8512695B2 (en) *	2008-10-21	2013-08-20	The General Hospital Corporation	Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188
US8114445B2 (en) *	2008-11-07	2012-02-14	Reliv International Inc.	Dietary supplement for promoting wellness and weight loss and methods of administering the same
US20100179089A1 (en) *	2009-01-13	2010-07-15	Deutz Nicolaas E P	Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
SG173832A1 (en)	2009-02-24	2011-09-29	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
WO2010110640A1 (en)	2009-03-24	2010-09-30	Universiti Putra Malaysia	Anti-diabetic nutraceutical composition from palm leaf extract
EP2311486A1 (en) *	2009-10-07	2011-04-20	Nestec S.A.	GLP-2 for use in intestine and muscle recovery
WO2012161670A2 (en)	2010-04-07	2012-11-29	Incube Labs, Llc	Method for treating diabetes and other glucose regulation disorders using stem cells
EP2592950B2 (en) *	2010-07-14	2022-11-30	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Isomaltulose for use in enhancing mental performance
WO2012019103A2 (en)	2010-08-06	2012-02-09	The General Hospital Corporation D/B/A	System and apparatus for cell treatment
CN101926431A (zh) *	2010-08-23	2010-12-29	贵阳高新创嘉创业服务有限公司	一种具有保健功能的组合物及其制备方法和用途
CN102007952A (zh) *	2010-09-26	2011-04-13	深圳职业技术学院	营养棒及其制备方法
JP2014521741A (ja) *	2011-08-16	2014-08-28	アボット・ラボラトリーズ	可溶性粘性繊維およびポリフェノール含有植物性抽出物を含む栄養組成物
AU2013204445B2 (en) *	2012-03-13	2014-10-02	Sapporo Holdings Limited	Nutritionally balanced food or beverage product
WO2013173719A1 (en) *	2012-05-18	2013-11-21	Metaproteomics, Llc	Phytonutrient compositions and methods of use
EA201591476A1 (ru)	2013-02-06	2016-02-29	Университет Брандайс	Лечение повреждений днк и митохондриальной дисфункции с применением сока плодов масличной пальмы
US9386790B2 (en)	2013-07-01	2016-07-12	University Of Southern California	Fasting condition as dietary treatment of diabetes
ITMI20131467A1 (it) *	2013-09-06	2015-03-07	Sofar Spa	Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
AU2014353872B2 (en) *	2013-11-19	2020-05-14	Omniblend Innovation Pty Ltd	Composition and method for control of post-prandial glucose
WO2015109231A1 (en) *	2014-01-17	2015-07-23	Cornell University	Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
US11191755B2 (en)	2014-01-17	2021-12-07	Cornell University	Compositions and methods for providing cardioprotective effects
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN108463121A (zh) *	2016-01-12	2018-08-28	南加利福尼亚大学	长期禁食模仿作为多发性骨髓瘤和其它癌症的膳食治疗的用途
IT201600083376A1 (it)	2016-08-08	2018-02-08	Sofar Spa	Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it)	2016-06-08	2017-12-08	Sofar Spa	Nuovo uso medico di probiotici
WO2017213961A1 (en) *	2016-06-10	2017-12-14	Gelesis Llc	Methods of inducing weight loss, treating obesity and preventing weight gain
EP3468670B1 (en)	2016-06-10	2023-12-13	University of Copenhagen	Predetermined diet for use in inducing weight loss and preventing weight gain
CN106490614A (zh) *	2016-10-31	2017-03-15	北京万源普达医疗科技有限公司	一种组合物及其作为糖尿病全营养配方食品的应用
IT201600122724A1 (it)	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
IT201600127498A1 (it)	2016-12-16	2018-06-16	Sofar Spa	Probiotici per uso nella diverticolosi e malattia diverticolare
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3612570A4 (en)	2017-04-17	2021-01-13	The University of Chicago	POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
US12110562B2 (en)	2017-06-01	2024-10-08	University Of Copenhagen	Compositions and methods for predicting and promoting weight loss
IL296055A (en)	2017-08-14	2022-10-01	Axcella Health Inc	Amino acid compositions for the treatment of liver disease
MA52971A (fr)	2018-06-20	2021-04-28	Axcella Health Inc	Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
CA3116822A1 (en) *	2018-12-13	2020-06-18	Societe Des Produits Nestle Sa	Methods for enhancing metabolic health in an animal
CN109528734A (zh) *	2019-01-24	2019-03-29	华纳时代健康科技（武汉）股份有限公司	一种复合营养组合物及其制备方法
CN110200276B (zh) *	2019-06-27	2023-04-07	刘东波	基于中药营养的组合物
US11751597B2 (en)	2019-11-05	2023-09-12	Alfasigma S.P.A.	Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
BR112023003513A2 (pt)	2020-09-01	2023-04-11	Shell Int Research	Composição de óleo de motor
CN114631628A (zh) *	2020-12-15	2022-06-17	中国科学院上海营养与健康研究所	一种增加血液fgf21浓度的方法
CN114794487A (zh) *	2021-01-22	2022-07-29	中国科学院上海营养与健康研究所	一种治疗糖尿病的方法
CN113785915A (zh) *	2021-08-05	2021-12-14	中山大学	一种甜味敏感的食物配方及其动物模型的构建方法
CN113521277A (zh) *	2021-08-27	2021-10-22	四川力量科技有限公司	一种康复糖尿病的产品及其制备方法
CN116473125A (zh) *	2022-01-17	2023-07-25	内蒙古伊利实业集团股份有限公司	一种缓释碳水组合物以及应用
CN116549428B (zh) *	2023-06-20	2025-05-16	郑州大学	4-羟基异亮氨酸的新用途
WO2026038577A1 (ja) *	2024-08-15	2026-02-19	太陽化学株式会社	飲食品摂取後の血中アミノ酸または消化管ホルモン濃度制御用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8317248D0 (en) *	1983-06-24	1983-07-27	Wyeth John & Brother Ltd	Fat compositions
US6140304A (en)	1988-09-28	2000-10-31	Eicotech Corporation	Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
CA2173780A1 (en) *	1995-06-01	1996-12-02	Randy Grote	Method for providing nutrition in a variety of compositional forms
MY115050A (en) *	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
PT780055E (pt) *	1995-10-27	2003-04-30	Nestle Sa	Composicao nutricional de cafe
DE69622722T2 (de) *	1996-11-20	2003-02-27	N.V. Nutricia, Zoetermeer	Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
DE69818594T2 (de) *	1997-06-23	2004-09-23	Société des Produits Nestlé S.A.	Verwendung einer nutritiven Zusammensetzung zur Herstellung einer flüssigen Zusammensetzung für Diabetiker
US5932258A (en) *	1998-04-06	1999-08-03	The Iams Company	Composition and process for improving glucose metabolism in companion animals
JP2000264844A (ja) *	1999-01-11	2000-09-26	Otsuka Pharmaceut Factory Inc	腎疾患患者用栄養組成物
US6440931B1 (en) *	1999-02-23	2002-08-27	Natural Corporation	Conjugated linoleic acid in treatment and prophylaxis of diabetes
US20020044988A1 (en) *	2000-08-22	2002-04-18	Fuchs Eileen C.	Nutritional composition and method for improving protein deposition
EP1358343A2 (en) *	2001-02-09	2003-11-05	Unilever N.V.	Process for the preparation of one or more statins by fermentation
US6605310B2 (en) *	2001-06-06	2003-08-12	Nestec S.A.	Calorically dense liquid oral supplement
MY135783A (en) *	2001-09-07	2008-06-30	Meiji Dairies Corp	Nutritional composition for controlling blood sugar level
PT1643861E (pt) *	2003-07-15	2011-07-05	Nestec Sa	Composição nutricional líquida rica em fibras alimentares e rica em calorias para a saúde intestinal no doente idoso
EP2243383A3 (en) *	2005-04-06	2011-02-16	Nestec S.A.	A method and composition for nutritionally improving glucose control and insulin action

2006
- 2006-04-04 EP EP10004584A patent/EP2243383A3/en not_active Withdrawn
- 2006-04-04 WO PCT/US2006/012576 patent/WO2006108008A2/en not_active Ceased
- 2006-04-04 EP EP06749290A patent/EP1868454B1/en not_active Revoked
- 2006-04-04 RU RU2007140731/13A patent/RU2421076C2/ru not_active IP Right Cessation
- 2006-04-04 CN CN201510501576.0A patent/CN105394748A/zh active Pending
- 2006-04-04 EP EP10004583A patent/EP2241195A1/en not_active Withdrawn
- 2006-04-04 PT PT67492900T patent/PT1868454E/pt unknown
- 2006-04-04 AU AU2006231557A patent/AU2006231557B2/en not_active Expired
- 2006-04-04 BR BRPI0608610-1A patent/BRPI0608610A2/pt not_active Application Discontinuation
- 2006-04-04 DK DK06749290.0T patent/DK1868454T3/da active
- 2006-04-04 US US11/910,817 patent/US8067359B2/en active Active
- 2006-04-04 CN CNA2006800167910A patent/CN101175416A/zh active Pending
- 2006-04-04 ES ES06749290T patent/ES2419205T3/es not_active Expired - Lifetime
- 2006-04-04 CA CA2601427A patent/CA2601427C/en not_active Expired - Lifetime
- 2006-04-04 JP JP2008505477A patent/JP5788631B2/ja not_active Expired - Lifetime
- 2006-04-04 MX MX2007012450A patent/MX2007012450A/es active IP Right Grant
- 2006-04-04 SG SG201002347-1A patent/SG161234A1/en unknown
2007
- 2007-09-13 ZA ZA200707825A patent/ZA200707825B/xx unknown
- 2007-09-17 IL IL186005A patent/IL186005A0/en unknown
2010
- 2010-07-12 AU AU2010202933A patent/AU2010202933A1/en not_active Abandoned
2011
- 2011-07-22 US US13/188,911 patent/US8697630B2/en not_active Expired - Lifetime
2013
- 2013-02-15 JP JP2013028114A patent/JP2013100353A/ja not_active Withdrawn
2015
- 2015-07-23 JP JP2015146014A patent/JP2015187182A/ja active Pending

Also Published As

Publication number	Publication date
ES2419205T3 (es)	2013-08-19
CA2601427C (en)	2013-06-11
EP2243383A2 (en)	2010-10-27
JP2008535840A (ja)	2008-09-04
SG161234A1 (en)	2010-05-27
WO2006108008A3 (en)	2007-01-18
AU2010202933A1 (en)	2010-07-29
US8067359B2 (en)	2011-11-29
EP1868454B1 (en)	2013-03-06
HK1113289A1 (en)	2008-10-03
PT1868454E (pt)	2013-04-03
CA2601427A1 (en)	2006-10-12
US8697630B2 (en)	2014-04-15
ZA200707825B (en)	2009-10-28
JP2013100353A (ja)	2013-05-23
JP2015187182A (ja)	2015-10-29
JP5788631B2 (ja)	2015-10-07
WO2006108008A2 (en)	2006-10-12
US20110305791A1 (en)	2011-12-15
RU2421076C2 (ru)	2011-06-20
EP1868454A2 (en)	2007-12-26
EP2243383A3 (en)	2011-02-16
CN105394748A (zh)	2016-03-16
EP2241195A1 (en)	2010-10-20
MX2007012450A (es)	2008-02-12
RU2007140731A (ru)	2009-05-20
AU2006231557B2 (en)	2010-09-09
US20080193603A1 (en)	2008-08-14
IL186005A0 (en)	2008-01-20
BRPI0608610A2 (pt)	2010-01-19
CN101175416A (zh)	2008-05-07
AU2006231557A1 (en)	2006-10-12

Publication	Publication Date	Title
DK1868454T3 (da)	2013-04-02	Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning
DK2135603T3 (da)	2013-03-25	Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet
DK3438131T3 (da)	2022-04-11	Oligosaccharidmodifikation og mærkning af proteiner
DK1951866T3 (da)	2014-10-27	Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer
DK1969846T3 (da)	2014-01-20	Systemer og fremgangsmåder til at administrere indhold
DK2227539T3 (da)	2017-11-13	Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær
DK3202779T3 (da)	2020-03-09	Hgh polypeptider med langtidsvirkning og anvendelser deraf
DK2188336T3 (da)	2013-12-02	Sammensætning omfattende et eller flere hydrofobt modificerede polyacrylamider og fremgangsmåde til anvendelse af sammensætningen
DK2066339T3 (da)	2014-11-03	Sammensætninger og fremgangsmåder til forstærkning af immunreaktioner
DK2185164T3 (da)	2017-11-13	Sammensætning og terapeutisk antitumorvaccine
DK2046819T3 (da)	2015-06-22	Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
DK1888033T3 (da)	2014-05-26	Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
NO20085030L (no)	2009-01-06	Pyrrolopyrimidinforbindelser og deres anvendelser
DK1968429T3 (da)	2013-07-08	Fremgangsmåde og system til stabilisering af sensorer
DK1969391T3 (da)	2014-10-27	Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1911358T3 (da)	2009-10-26	Ny sammensætning til forbedring af hudkvalitet og fremgangmåde til fremstilling deraf
DE602006020159D1 (de)	2011-03-31	Härtbare silikonzusammensetzung
DE602007001492D1 (de)	2009-08-20	Schubkraftkorrektur
DK2029799T3 (da)	2012-12-10	Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
EP2116535A4 (en)	2013-05-29	GLUCOKINASE ACTIVATING SUBSTANCE
DK2068891T3 (da)	2014-01-13	Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK2172207T3 (da)	2013-04-08	Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf
DK2013554T3 (da)	2017-11-27	Styreenhed til kølesystem og fremgangsmåde
DK1917253T3 (da)	2015-03-30	Fremgangsmåde til fremstilling af betamimetika